Who are Sodium Bicarbonate Powder and ondansetron's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodium-bicarbonate-powder-and-ondansetron.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Sodium Bicarbonate Powder and ondansetron — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sodium Bicarbonate Powder and ondansetron (Sodium Bicarbonate Powder and ondansetron) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antacid and antiemetic combination. Area: Gastroenterology.

marketed Antacid and antiemetic combination 5-HT3 receptor (ondansetron); non-specific acid neutralization (sodium bicarbonate) Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Sodium Bicarbonate Powder and ondansetron (Sodium Bicarbonate Powder and ondansetron) — Aya Sabry Mohamed Mohamed. This combination uses sodium bicarbonate to neutralize gastric acid and ondansetron to block serotonin receptors and prevent nausea and vomiting.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Sodium Bicarbonate Powder and ondansetron TARGET	Sodium Bicarbonate Powder and ondansetron	Aya Sabry Mohamed Mohamed	marketed	Antacid and antiemetic combination	5-HT3 receptor (ondansetron); non-specific acid neutralization (sodium bicarbonate)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antacid and antiemetic combination class)

Aya Sabry Mohamed Mohamed · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sodium Bicarbonate Powder and ondansetron — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-bicarbonate-powder-and-ondansetron. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab